LifeMD Inc
$ 2.67
1.14%
24 Feb - close price
- Market Cap 128,523,000 USD
- Current Price $ 2.67
- High / Low $ 2.79 / 2.56
- Stock P/E N/A
- Book Value 0.03
- EPS -0.25
- Next Earning Report 2026-03-09
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.03 %
- ROE -22.43 %
- 52 Week High 15.84
- 52 Week Low 2.56
About
LifeMD, Inc. is a direct-to-patient telehealth company connecting consumers with healthcare professionals for care in various indications, including concierge care, men's sexual health, dermatology, and others in the United States. . The company is headquartered in New York, New York.
Analyst Target Price
$9.25
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-17 | 2025-08-05 | 2025-05-06 | 2025-03-10 | 2024-11-07 | 2024-08-07 | 2024-05-08 | 2024-03-11 | 2023-11-08 | 2023-08-09 | 2023-05-12 | 2023-03-22 |
| Reported EPS | -0.1 | -0.06 | 0.0282 | 0.21 | -0.14 | -0.19 | -0.19 | -0.12 | -0.2 | -0.23 | -0.15 | -0.4 |
| Estimated EPS | -0.04 | -0.02 | 0.14 | 0.14 | -0.12 | -0.12 | -0.15 | -0.14 | -0.15 | -0.1 | -0.16 | -0.18 |
| Surprise | -0.06 | -0.04 | -0.1118 | 0.07 | -0.02 | -0.07 | -0.04 | 0.02 | -0.05 | -0.13 | 0.01 | -0.22 |
| Surprise Percentage | -150% | -200% | -79.8571% | 50% | -16.6667% | -58.3333% | -26.6667% | 14.2857% | -33.3333% | -130% | 6.25% | -122.2222% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-09 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.01 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: LFMD
2026-02-20 16:25:19
Nine research firms have given LifeMD, Inc. (NASDAQ:LFMD) an average recommendation of "Moderate Buy," with an average 12-month price target of $9.25, suggesting significant upside from its current price of approximately $2.90. However, recent analyst actions indicate weakening sentiment, with several firms lowering price targets and one downgrading the stock to "sell." The company recently missed quarterly earnings and revenue estimates, and notable insider selling has occurred.
2026-02-20 02:36:00
This article analyzes Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: LFMDP) using AI models. It identifies a strong near-term sentiment but a neutral mid and long-term outlook, highlighting an exceptional 12.0:1 risk-reward setup. The analysis provides specific trading strategies for different risk profiles, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis.
2026-02-13 22:57:22
LifeMD, Inc. (LFMD) is presented as a direct-to-patient telehealth company with significant growth potential, indicated by a 230.36% upside based on analyst target prices. Despite not yet achieving positive net income and showing some bearish technical indicators, the company's innovative telehealth services and digital solutions, coupled with strong analyst support, make it an attractive proposition for investors interested in the healthcare technology market. LifeMD's diverse offerings and capacity for revenue growth position it as a company to watch, albeit with considerations for current financial metrics and market volatility.
2026-02-12 18:27:43
LifeMD, Inc. (NASDAQ:LFMD) shares have dropped 31% in the last month, contributing to a 58% loss over the past year. This decline is attributed to concerns about the company's future revenue growth, with analysts forecasting a 1.3% annual contraction over the next three years, contrasting with an expected 13% annual growth for the broader Healthcare Services industry. As a result, the company's low price-to-sales ratio of 0.6x reflects investor sentiment regarding its current and future financial outlook, making the share price plunge unsurprising.
2026-02-03 15:59:29
This article indicates that options trading for LifeMD (LFMD) suggests an expected share price movement of 13.7% following its upcoming earnings report. The implied volatility from options prices is used to forecast potential stock fluctuations after the announcement.
2026-01-30 05:28:42
LifeMD, Inc. (NASDAQ:LFMD) has received a consensus "Moderate Buy" rating from nine brokerages, with an average 12-month price target of $9.25, despite recently missing quarterly earnings and revenue estimates. Insider selling by the CMO was reported, but several institutional investors, including Arrowstreet, JPMorgan, Jump Financial, and Invesco, significantly increased their positions in the company. The telehealth stock has a market cap of $172.34 million and is trading around $3.58.
